HPV Testing With 16, 18, and 45 Genotyping Stratifies Cancer Risk for Women With Normal Cytology - Concepedia

Concepedia

Publication | Open Access

HPV Testing With 16, 18, and 45 Genotyping Stratifies Cancer Risk for Women With Normal Cytology

DOI Full Paper Access

32

Citations

42

References

2018

Year

Mark H. Stoler, Thomas C. Wright, Valentin Parvu, Karen Yanson, Karen Eckert, Salma Kodsi, Charles K. Cooper

American Journal of Clinical Pathology

Abstract

Onclarity is clinically validated for cotesting in NILM women. Genotyping actionably stratifies women at greater CIN3 or higher risk.

References

	Year	Citations

Page 1